All In Biotech

Drug Trial Radar · NCT01963208

Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension

A Multicenter, Double Blind, Randomized, Placebo-Controlled Trial to Determine the Efficacy and Safety of Ganaxolone as Adjunctive Therapy for Adults With Drug-Resistant Partial-Onset Seizures Followed by Long-term Open-Label Treatment

Last checked: Nov 19, 2026Latest source record: Feb 14, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 405 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

405

Actual

Start

Oct 2013

Primary completion

May 2016

Study completion Oct 2016

Sponsor

Lead sponsor
Marinus PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Oct 16, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study will evaluate the effectiveness and safety of an investigational drug-ganaxolone - on partial seizure frequency in adults with epilepsy taking a maximum of 3 antiepileptic medications (AEDs).

Conditions

  • Drug Resistant Partial Onset Seizure

Interventions

  • ganaxoloneDrug

    200 mg and 225 mg capsules; target dose 1800 mg/day dosed 900mg 2x/day

  • PlaceboDrug

    placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Double Blind: Cohort 2: Percent Change From Baseline in 28-day Seizure Frequency During Titration + Maintenance PeriodTime frame: Baseline and Week 14

Locations

71 sites in 6 countries. Site status is shown where the registry gives one.

  • University of Alabama Epilepsy Center

    Birmingham, Alabama

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • Xenoscience Inc.

    Phoenix, Arizona

  • The MORE Foundation

    Sun City, Arizona

  • Clinical Trials Inc.

    Little Rock, Arkansas

  • Neuro-Pain Medical Center, Inc

    Fresno, California

  • Neurological Research Institute

    Santa Monica, California

  • University of Colorado- Anschutz Outpatient Pavilion

    Aurora, Colorado

  • Neuroscience Consulants

    Miami, Florida

  • Medsol Clinical Research Center

    Port Charlotte, Florida

  • Consultants in Epilepsy & Neurology

    Boise, Idaho

  • Bluegrass Epilepsy Research, LLC

    Lexington, Kentucky

  • Mid-Atlantic Epilepsy Center

    Bethesda, Maryland

  • Bringham and Women's Hospital

    Boston, Massachusetts

  • Minneapolis Clinic of Neurology

    Golden Valley, Minnesota

  • The Comprehensive Epilepsy Care Center for Children and Adults

    Chesterfield, Missouri

  • Cooper Medical Center of Rowan University

    Camden, New Jersey

  • Northeast Regional Epilepsy Group

    Hackensack, New Jersey

  • Five Towns Neuroscience Research

    Cedarhurst, New York

  • Northeast Regional Epilepsy Group

    Middletown, New York

  • Winthrop University Hospital

    Mineola, New York

  • New York University Comprehensive Epilepsy Center

    New York, New York

  • Northeast Regional Epilepsy Group

    New York, New York

  • Wake Forest Health Sciences

    Winston-Salem, North Carolina

  • Ohio Clinical Research Partners, LLC

    Canton, Ohio

  • Ohio State University

    Columbus, Ohio

  • Lynn Health Institute

    Oklahoma City, Oklahoma

  • Sooner Clinical Research

    Oklahoma City, Oklahoma

  • Jefferson Comprehensive Epilepsy Center

    Philadelphia, Pennsylvania

  • Temple University School of Medicine

    Philadelphia, Pennsylvania

  • Neurology Consultants of Dallas

    Dallas, Texas

  • Texas Epilepsy Group

    Dallas, Texas

  • Rainier Clinical Research Center, Inc.

    Renton, Washington

  • Royal Prince Alfred Hospital

    Camperdown, New South Wales, Australia

  • The Prince of Wales Hospital

    Randwick, New South Wales, Australia

  • Westmead Hospital

    Westmead, New South Wales, Australia

  • Flinders Medical Center

    Bedford Park, South Australia, Australia

  • St. Vincent's Hospital

    Fitzroy, Victoria, Australia

  • The Florey Institute of Neuroscience and Mental Health

    Heidelberg, Victoria, Australia

  • The Royal Melbourne Hospital

    Parkville, Victoria, Australia

Showing 40 of 71 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.